Cooperative action of 1α,25-dihydroxyvitamin D3 and retinoic acid in NB4 acute promyelocytic leukemia cell differentiation is transcriptionally controlled

Experimental Cell Research

Volumn 310, Issue 2, 2005, Pages 319-330

  Bastie, Jean Noël ^a   Balitrand, Nicole ^a   Guillemot, Isabelle ^a   Chomienne, Christine ^a   Delva, Laurent ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

1 ,25 dihydroxyvitamin D3; Granulocytic differentiation; Promyelocytic cells; Retinoic acid

Indexed keywords

CALCITRIOL; CALCITRIOL RECEPTOR; RETINOIC ACID; RETINOIC ACID RECEPTOR BETA; ANTINEOPLASTIC AGENT; RETINOIC ACID RECEPTOR;

ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GRANULOCYTE; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROMYELOCYTIC LEUKEMIA; TRANSCRIPTION REGULATION; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MYELOID PROGENITOR CELL; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; CALCITRIOL; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MYELOID PROGENITOR CELLS; RECEPTORS, CALCITRIOL; RECEPTORS, RETINOIC ACID; TRANSCRIPTION, GENETIC; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 26844483998     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2005.08.001     Document Type: Article

References (80)

1. D. Douer, and H.P. Koeffler Retinoic acid enhances growth of human early progenitor cells in vitro J. Clin. Invest. 69 1982 1039 1041
2. H.P. Koeffler, T. Amatruda, N. Ikekawa, Y. Kobayashi, and H.F. DeLuca Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxy vitamin D3 and its fluorinated analogues Cancer Res. 44 1984 5624 5628
3. R. Lotan Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells Biochem. Biophys. Acta 605 1980 33 91
4. H.L. Henry, and A.W. Norman Vitamin D: metabolism and biological actions Annu. Rev. Nutr. 4 1984 493 498
5. A.W. Norman, J. Roth, and L. Orci The vitamin D endocrine system: steroid metabolism, hormone receptors and biological response (calcium binding proteins) Endocr. Rev. 3 1982 331 366
6. S. Green, and P. Chambon Carcinogenesis: a superfamily of potentially oncogenic hormone receptors Nature 324 1986 615 617
7. P. Chambon A decade of molecular biology of retinoic acid receptor FASEB J. 10 1996 940 954
8. M. Schräder, S. Nayeri, K.M. Muller, J.P. Kahlen, and C. Carlberg Natural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D receptor-retinoid X receptor heterodimer-mediated transactivation Mol. Cell. Biol. 15 1995 1154 1161
9. C. Zechel, X.Q. Shen, P. Chambon, and H. Gronemeyer The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats EMBO J. 13 1994 1425 1433
10. C.K. Glass Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers Endocr. Rev. 15 1994 391 407
11. P. Garcia-Villalba, A.M. Jiménez-Lara, and A. Aranda Vitamin D interferes with transactivation of the growth hormone gene by thyroid hormone and retinoic acid Mol. Cell. Biol. 16 1996 318 327
12. A.M. Jiménez-Lara, and A. Aranda The vitamin D receptor binds in a transcriptionally inactive form and without a defined polarity on a retinoic acid response element FASEB J. 13 1999 1073 1081
13. M. Quack, K. Szafranski, J. Rouvinen, and C. Carlberg The role of the T-box for the function of the vitamin D receptor on different types of response elements Nucleic Acids Res. 26 1998 5372 5378
14. M. Quack, and C. Carlberg Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs Mol. Pharmacol. 55 1999 1077 1087
15. P.M. Yen, Y. Liu, A. Sugawara, and W.W. Chin Vitamin D receptors repress basal transcription and exert dominant negative activity on triiodothyronine- mediated transcriptional activity J. Biol. Chem. 271 1996 10910 10916
16. X. Song, H.M. Sheppard, A.W. Norman, and X. Liu Mitogen-activated protein kinase is involved in the degradation of p53 protein in the bryostatin-1-induced differentiation of the acute promyelocytic NB4 cell line J. Biol. Chem. 274 1999 1677 1682
17. D.M. Berry, R. Antochi, M. Bhatia, and K.A. Meckling-Gill 1,25-dihydroxyvitamin D3 stimulates expression and translocation of protein kinase Calpha and Cdelta via a nongenomic mechanism and rapidly induces phosphorylation of a 33-kDa protein in acute promyelocytic NB4 cells J. Biol. Chem. 271 1996 16090 16096
18. D.M. Berry, C.S. Clark, and K.A. Meckling-Gill 1alpha,25-dihydroxyvitamin D3 stimulates phosphorylation of IkappaBalpha and synergizes with TPA to induce nuclear translocation of NFkappaB during monocytic differentiation of NB4 leukemia cells Exp. Cell Res. 272 2002 176 184
19. B. Rohe, S.E. Safford, I. Nemere, and M.C. Farach-Carson Identification and characterization of 1,25D3-membrane-associated rapid response, steroid (1,25D3-MARRS)-binding protein in rat IEC-6 cells Steroids 70 2005 458 463
20. D. Douer, L. Ramezani, J. Parker, and A.M. Levine All-trans retinoic acid affects the growth, differentiation and apoptosis of normal human myeloid progenitors derived from purified CD34+ bone marrow cells Leukemia 14 2000 874 881
21. M. Kreutz, R. Andreesen, S.W. Krause, A. Szabo, E. Ritz, and H. Reichel 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages Blood 82 1993 1300 1307
22. A. Nagler, I. Riklis, Y. Kletter, I. Tatarsky, and I. Fabian Effect of 1,25-dihydroxyvitamin D3 and retinoic acid on normal human pluripotent (CFU-mix), erythroid (BFU-E), and myeloid (CFU-C) progenitor cell growth and differentiation patterns Exp. Hematol. 14 1986 60 65
23. A. Sakashita, M. Kizaki, S. Pakkala, G. Schiller, N. Tsuruoka, R. Tomosaki, J.F. Cameron, M.I. Dawson, and H.P. Koeffler 9-cis retinoic acid: effects on normal and leukemic hematopoiesis in vitro Blood 81 1993 1009 1016
24. E. Abe, C. Miyaura, H. Sakagami, M. Takeda, K. Konno, T. Yamazaki, S. Yoshiki, and T. Suda Differentiation of mouse leukemia cells induced by 1α,25-dihydroxyvitamin D3 Proc. Natl. Acad. Sci. U. S. A. 78 1981 4990 4993
25. C. Chomienne, P. Ballerini, N. Balitrand, M.T. Daniel, S. Castaigne, and L. Degos All-trans retinoic acid in acute promyelocytic leukemias: II. In vitro studies: structure-function relationship Blood 76 1990 1710 1717
26. R. Di Noto, C. Lo Pardo, E.M. Schiavone, F. Ferrara, C. Manzo, C. Vacca, and L. Del Vecchio All-trans retinoic acid (ATRA) and the regulation of adhesion molecules in acute myeloid leukemia Leuk. Lymphoma 21 1996 201 209
27. H.P. Koeffler Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications Blood 62 1983 709 721
28. A. Muto, M. Kizaki, K. Yamato, Y. Kawai, M. Kamata-Matsushita, H. Ueno, M. Ohguchi, T. Nishihara, H.P. Koeffler, and Y. Ikeda 1,25-dihydroxy vitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21WAF1/CIP1 and p27KIP1 Blood 93 1999 2225 2233
29. G. Brown, C.M. Bunce, D.C. Rowlands, and G.R. Williams All-trans retinoic acid and 1α, 25-dihydroxyvitamin D3 co-operate to promote differentiation of the human promyeloid leukemia cell line HL-60 to monocytes Leukemia 8 1994 806 815
30. B.T. Doré, M.R. Uskokovic, and R.L. Momparler Interaction of retinoic acid and vitamin D3 analogues on HL-60 myeloid leukemic cells Leuk. Res. 17 1993 749 757
31. M.T. Drayson, R.H. Michell, J. Durham, and G. Brown Cell proliferation and CD11b expression are controlled independently during HL60 cell differentiation initiated by 1,25 alpha-dihydroxyvitamin D(3) or all-trans-retinoic acid Exp. Cell Res. 266 2001 126 134
32. D.J. Mangelsdorf, H.P. Koeffler, C.A. Donaldson, J.W. Pike, and M.R. Hausler 1,25-Di-hydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells J. Cell Biol. 98 1984 391 398
33. H. Tanaka, E. Abe, C. Miyaura, T. Kuribayashi, K. Konno, Y. Nishi, and T. Suda 1,25-Di-hydrocholecalciferol and a human myeloid leukemia cell line (HL-60) Biochem. J. 204 1982 713 719
34. I.D. Trayner, T. Bustorff, A.E. Etches, G.J. Mufti, Y. Foss, and F. Farzaneh Changes in antigen expression on differentiating HL60 cells treated with dimethylsulphoxide, all-trans retinoic acid, alpha1,25-dihydroxyvitamin D3 or 12-O-tetradecanoyl phorbol-13-acetate Leuk. Res. 22 1998 537 547
35. R.C. Dodd, M.S. Cohen, S.L. Newman, and T.K. Gray Vitamin D metabolites change the phenotype of monoblastic U937 cells Proc. Natl. Acad. Sci. U. S. A. 80 1983 7538 7541
36. M. Liu, M.H. Lee, M. Cohen, M. Bommakanti, and L.P. Freedman Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937 Genes Dev. 10 1996 142 153
37. I.L. Olsson, U. Gulberg, I. Ivhed, and K. Nilsson Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1,25-dihydrocholecalciferol Cancer Res. 42 1983 3924 3927
38. W.F.C. Rigby, L. Shen, E.D. Ball, P.M. Guyre, and M.W. Fanger Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D3 (calcitriol): a morphologic, phenotypic and functional analysis Blood 64 1984 1110 1115
39. M. Taimi, M.T. Château, S. Cabane, and J. Marti Synergistic effect of retinoic acid and 1α,25-dihydroxyvitamin D3 on the differentiation of the human monocytic cell line U-937 Leuk. Res. 15 1991 1145 1152
40. A. Spittler, M. Willheim, F. Leutmezer, R. Ohler, W. Krugluger, C. Reissner, T. Lucas, T. Brodowicz, E. Roth, and G. Boltz-Nitulescu Effects of 1 alpha,25-dihydroxyvitamin D3 and cytokines on the expression of MHC antigens, complement receptors and other antigens on human blood monocytes and U937 cells: role in cell differentiation, activation and phagocytosis Immunology 90 1997 286 293
41. T.R. Breitman, S.E. Selonick, and S.J. Collins Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid Proc. Natl. Acad. Sci. U. S. A. 77 1980 2936 2940
42. R. Manfredini, F. Trevisan, A. Grande, A. Tagliafico, M. Montanari, R. Lemoli, G. Visani, S. Tura, S. Ferrari, and S. Ferrari Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells Cancer Res. 59 1999 3803 3811
43. I.L. Olsson, and T.R. Breitman Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3′: 5′-monophosphate-inducting agents Cancer Res. 42 1982 3924 3927
44. M. Liu, A. Iavarone, and L.P. Freedman Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation J. Biol. Chem. 271 1996 31723 31728
45. J.N. Bastie, N. Balitrand, F. Guidez, I. Guillemot, J. Larghero, C. Calabresse, C. Chomienne, and L. Delva 1α,25-dihydroxyvitamin D3 transrepresses retinoic acid transcriptional activity via vitamin D receptor in myeloid cells Mol. Endocrinol. 18 2004 2685 2699
46. S. Castaigne, C. Chomienne, M.T. Daniel, P. Ballerini, R. Berger, P. Fenaux, and L. Degos All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results Blood 76 1990 1704 1709
47. R.L. Redner, J. Wang, and J.M. Liu Chromatin remodeling and leukemia: new therapeutic paradigms Blood 94 1999 417 428
48. P.P. Pandolfi Transcription therapy for cancer Oncogene 20 2001 3116 3127
49. A. Melnick, and J.D. Licht Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia Blood 93 1999 3167 3215
50. R.J. Lin, T. Sternsdorf, M. Tini, and R.M. Evans Transcriptional regulation in acute promyelocytic leukemia Oncogene 20 2001 7204 7215
51. M. Lanotte, V. Martin-Thouvenin, S. Najman, P. Ballerini, F. Valensi, and R. Berger NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia Blood 77 1991 1080 1086
52. M. Bhatia, J.B. Kirkland, and K.A. Meckling-Gill M-CSF and 1,25 Dihydroxyvitamin D3 synergize with 12-O-tetradecanoylphorbol-13-acetate to induce macrophage differentiation in acute promyelocytic leukemia NB4 cells Leukemia 8 1994 1744 1749
53. C.S. Clark, J.E. Konyer, and K.A. Meckling 1alpha,25-dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression Exp. Cell Res. 294 2004 301 311
54. H. de Thé, P. M.D.M. Vivanco-Ruiz, H. Tiollais, and A. Stunnenberg Identification of a retinoic acid responsive element in the retinoic acid receptor β gene Nature 343 1990 177 180
55. L. Delva, J.N. Bastie, C. Rochette-Egly, R. Kraïba, N. Balitrand, G. Despouy, P. Chambon, and C. Chomienne Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex Mol. Cell. Biol. 19 1999 7158 7167
56. B. Cassinat, F. Zassadowski, N. Balitrand, C. Barbey, J.D. Rain, P. Fenaux, L. Degos, M. Vidaud, and C. Chomienne Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR Leukemia 14 2000 324 328
57. M. Gianni', M. Terao, C. Gambacorti-Passerini, A. Rambaldi, and E. Garattini Effects of 1,25-dihydroxy vitamin D3 on all-trans retinoic acid sensitive and resistant acute promyelocytic leukemia cells Biochem. Biophys. Res. Commun. 224 1996 50 56
58. A. Chen, J.D. Licht, Y. Wu, N. Hellinger, W. Scher, and S. Waxman Retinoic acid is required for and potentiates differentiation of acute promyelocytic leukemia cells by nonretinoid agents Blood 84 1994 2122 2129
59. H. Yoshida, K. Kitamura, K. Tanaka, S. Omura, T. Miyazaki, T. Hachiya, R. Ohno, and T. Naoe Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway Cancer Res. 56 1996 2945 2948
60. J.V. Raelson, C. Nervi, A. Rosenauer, L. Benedetti, Y. Monczak, M. Pearson, P.G. Pelicci, and W.H. Miller Jr. The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells Blood 88 1996 2826 2832
61. J. Zhu, M. Gianni, E. Kopf, N. Honoré, M. Chelbi-Alix, M. Koken, F. Quignon, C. Rochette-Egly, and H. de Thé Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins Proc. Natl. Acad. Sci. U. S. A. 96 1999 14807 14812
62. M. Fanelli, S. Minucci, V. Gelmetti, C. Nervi, C. Gambacorti-Passerini, and P.G. Pelicci Constitutive degradation of PML/RARalpha through the proteasome pathway mediates retinoic acid resistance Blood 93 1999 1477 1481
63. Y. Jing, L. Xia, and S. Waxman Targeted removal of PML-RARalpha protein is required prior to inhibition of histone deacetylase for overcoming all-trans retinoic acid differentiation resistance in acute promyelocytic leukemia Blood 100 2002 1008 1013
64. S. Kitareewan, I. Pitha-Rowe, D. Sekula, C.H. Lowrey, M.J. Nemeth, T.R. Golub, S.J. Freemantle, and E. Dmitrovsky UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia Proc. Natl. Acad. Sci. U. S. A. 99 2002 3806 3811
65. B. Cassinat, S. Chevret, F. Zassadowski, N. Balitrand, I. Guillemot, M.L. Menot, L. Degos, P. Fenaux, C. Chomienne European APL Group In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome Blood 98 2001 2862 2864
66. D.M. Berry, K. Williams, and K.A. Meckling-Gill All trans retinoic acid induces apoptosis in acute promyelocytic NB4 cells when combined with isoquinolinediol, a poly(ADP-ribose) polymerase inhibitor Leuk. Res. 24 2000 307 316
67. M. Bhatia, J.B. Kirkland, and K.A. Meckling-Gill 1,25-dihydroxyvitamin D3 primes acute promyelocytic cells for TPA-induced monocytic differentiation through both PKC and tyrosine phosphorylation cascades Exp. Cell Res. 222 1996 61 69
68. S. Moqattash, and J.D. Lutton Leukemia cells and the cytokine network: a review of the literature Proc. Soc. Exp. Biol. Med. 219 1998 8 27
69. P. Dhawan, X. Peng, A.L. Sutton, P.N. MacDonald, C.M. Croniger, C. Trautwein, M. Centrella, T.L. McCarthy, and S. Christakos Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase Mol. Cell. Biol. 25 2005 472 487
70. E. Puccetti, D. Obradovic, T. Beissert, A. Bianchini, B. Washburn, F. Chiaradonna, S. Boehrer, D. Hoelzer, O.G. Ottmann, P.G. Pelicci, C. Nervi, and M. Ruthardt AML-associated translocation products block vitamin D3-induced differentiation by sequestering the vitamin D3 receptor Cancer Res. 62 2002 7050 7058
71. F. Grignani, P.F. Ferrucci, U. Testa, G.P. Talamo, M. Fagioli, M. Alcalay, A. Mencarelli, F. Grignani, C. Peschle, I. Nicoletti, and P.G. Pelicci The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells Cell 74 1993 423 431
72. M. Ruthardt, U. Testa, C. Nervi, P.F. Ferrucci, F. Grignani, E. Puccetti, F. Grignani, C. Peschle, and P.G. Pelicci Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling Mol. Cell. Biol. 17 1997 4859 4869
73. P. Rousselot, B. Hardas, A. Patel, F. Guidez, J. Gaken, S. Castaigne, A. Dejean, H. de Thé, L. Degos, F. Farzaneh, and C. Chomienne The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells Oncogene 9 1994 545 551
74. J. Lotem, and L. Sachs Epigenetics wins over genetics: induction of differentiation in tumor cells Semin. Cancer Biol. 12 2002 339 346
75. G.P. Studzinski, J.A. McLane, and M.R. Uskokovic Signaling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases Crit. Rev. Eukaryotic Gene Expression 3 1993 279 312
76. Z. Hmama, D. Nandan, L. Sly, K.L. Knutson, P. Herrera-Velit, and N.E. Reiner 1alpha,25-dihydroxyvitamin D(3)-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex J. Exp. Med. 190 1999 1583 1594
77. M. Hewison, M. Dabrowski, S. Vadher, L. Faulkner, F.J. Cockerill, P.M. Brickell, J.L. O'Riordan, and D.R. Katz Antisense inhibition of vitamin D receptor expression induces apoptosis in monoblastoid U937 cells J. Immunol. 156 1996 4391 4400
78. D. Pasquali, P. Chieffi, W.J. Deery, G. Nicoletti, A. Bellastella, and A.A. Sinisi Differential effects of all-trans-retinoic acid (RA) on Erk1/2 phosphorylation and cAMP accumulation in normal and malignant human prostate epithelial cells: Erk1/2 inhibition restores RA-induced decrease of cell growth in malignant prostate cells Eur. J. Endocrinol. 152 2005 663 669
79. D.G. Tenen, R. Hromas, J.D. Licht, and D.E. Zhang Transcription factors, normal myeloid development, and leukemia Blood 90 1997 489 519
80. S.H. Orkin Diversification of haematopoietic stem cells to specific lineages Nat. Rev. Genet. 1 2000 57 64